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The  fact  that  group  A  hemolytic streptococci produce  an  extracellular 
desoxyribonuclease in  appreciable  amounts  has  recently been  encountered 
independently in two different laboratories (1, 2). The production of this en- 
zyme appears to be a relatively constant property of these organisms,  as in- 
dicated by the fact that it is elaborated by a wide variety of strains derived 
from different sources  and with  diverse biological  properties.  The possible 
significance of desoxyribonuclease  in the pathogenesis of streptococcal disease 
is not known, although it seems certain that it does not act as a primary toxic 
agent. 
In the case of other extracellular products of group A streptococci--such as 
streptokinase, streptolysin O, and hyaluronidase--it has been established that 
antibodies directed against them are highly effective in  inhibiting their bio- 
logical activity. The present investigation was undertaken to determine whether 
streptococcal desoxyribonudease is  similarly  inhibited by its  antibody and 
whether this antibody is commonly formed by human patients subsequent to 
streptococcal infections.  It has previously been shown that rabbit  antiserum 
against bovine pancreatic desoxyribonudease effectively inhibits this enzyme 
(3). An opportunity was thus provided for a comparison of the antibody inhibi- 
tion of two enzymes having similar action but prepared from widely different 
SOurCeS. 
Materials  and Methods 
Preparation of Streptocorxal Desoxyribonuzlease.--The enzyme was prepared  in a  highly 
active form from supernates of cultures of a strain of group A hemolytic streptococcus. The 
procedure used in the preparation of the material Used in most of this study is described in 
the following: 
Fifteen liters of neopeptone dialysate broth (4) was inoculated with strain  H105 and in- 
cubated at 37 ° for 20 hours. The cells were removed by centrifugation in a Sharples centrifuge 
and the slightly turbid supernate was brought to 0.4 saturation with ammonium sulfate by 
the addition of 243 gin. of solid salt per liter of supernate. One-tenth per cent each of filter 
cel and hyflo super cel were added and the suspension filtered with suction. The clear filtrate 
was brought to 0.8 saturation  by the addition of 281 gin. of ammonium sulfate per liter of 
filtrate and the resulting precipitate recovered by filtration. The solution of this  precipitate 
in 100 cc. distilled water was dark brown in color and contained practically all of the original 
desoxyribonuclease activity. Further fractionation was carried out with ammonium sulfate 
The solution was brought to 0.4 saturation and a precipitate formed which contained most 
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of the colored material but only about 15 per cent of the total activity. The bulk of the activity 
was  recovered by bringing the 0.4 saturated supernate to 0.5 saturation.  The precipitate so 
formed was recovered by filtration, dissolved in a  small volume of water,  dialyzed against 
distilled water, and dried in vacuo from the frozen state. The yield was 169 nag. of dried ma- 
terial with an activity of 25,000 viscosity units per rag. which is approximately 2.5 times that 
of the amorphous desoxyribonuclease prepared from beef pancreas by the method previously 
described (3).  It did not contain measurable amounts of streptokinase or streptococcal pro- 
teinase. 
Some increase in the initial production of enzyme can be obtained by the addition of ex- 
cess glucose and growth factors after overnight incubation and continued growth of the cul- 
ture with neutralization of the acid formed. However, with the strain used, the increase has 
never  been more than twofold, which is small compared to the ten- to thirtyfold increase in 
streptokinase concentration which occurs at the same time. The results reported by Christensen 
(5) using a strain of group C also indicate a disparity between the production of streptokinase 
and desoxyribonuclease under these conditions, although the increase in desoxyribonudease 
appears to be greater than that obtained with group A strains in this laboratory. 
Recovery of Streptococcal Desoxyribonuclease  from Streptokinase Preparation.--As  observed 
by Tillett, Sherry, and Christensen  (1), streptokinase purified by the method of Christensen 
contains relatively large amounts of desoxyHbonuclease. Christensen (5) has described methods 
for partial separation of the desoxyribonuclease from streptokinase preparations from group 
C strains, and analogous results have been obtained independently in this laboratory in the 
fractionation of group A  streptokinase. 
Streptokinase purified  by a  modification of Christensen's procedure (6)  was subjected to 
further fractionation with ammonium sulfate. Immediately following protamine precipitation, 
a concentrated solution of streptokinase was brought to 0.5 saturation by the addition of an 
equal volume of saturated  (NH4)2SO4. The streptokinase was precipitated  almost quanti- 
tatively, and  subsequent precipitation of the supernate at 0.8 saturation  yielded a  fraction 
containing 60 per cent of the desoxyribonudease and only 0.01 per cent of the streptokinas¢ 
of the original material. The specific activity of the desoxyribonuclease so obtained is essen- 
tially the same as that of the preparation  described above. 
Preparagion of Substrale.--The  desoxyribonucleate used as substrate was obtained  by de- 
proteinization of calf thymus nucieohistone prepared according to the method of Mirsky and 
Pollister (7). Deproteinization by the chloroform method requires numerous repetitions of the 
process and is especially cumbersome if the preparation of moderately large amounts of ma- 
terial is attempted. A method has been devised to facilitate the removal of protein which is 
based on the procedure used for the separation of pneumococcal nucleic acid and pneumococcal 
polysaccharides by the use of CaCI: and ethyl alcohol (8). The amount of chloroform treatment 
required is greatly reduced. 
The solution  of nucleohistone  in x¢ NaCI is mixed with an equal volume of 0.9 x¢ CaCh. 
The volume of the solution is measured and 0.2 volume of ethyl alcohol added with stirring. 
The desoxyribonucieate separates out as a fibrous precipitate which is removed and washed 
twice in a solution containing CaCI2 and alcohol in the same concentration as that from which 
it was precipitated. The bulk of the protein remains in solution. The fibrous precipitate is re- 
dissolved in x¢ NaC1 and final deproteinization carried out by the chloroform method. Varia- 
tions are experienced from lot to lot in the ease with which the last fraction of protein is re- 
moved. In some eases it is difficult to obtain nucleate which gives water-clear solutions and 
negative qualitative tests for protein. 
Rabbit Antisera  against Streptococcal Desoxyribonuclease.--The  enzyme was injected intra- 
peritoneally into rabbits in the form of an slum precipitate. Aqueous solutions of the enzyme 
were mixed with an equal volume of 10 per cent aluminum potassium sulfate and the solution MACLYN  McCARTY  545 
brought to neutrality with N NaOH  to precipitate the alum. The rabbits received weekly 
doses of 2, 2, 10, and 10 rag. of the enzyme purified according to the method described above, 
and blood was obtained for serum 5 days after the last dose. 
Human Sera.--The human sera were those from an epidemic of scarlet fever occurring at 
the Great Lakes Naval Training Center from February, to May, 1946.1 In a previous study, 
the antistreptokinase and  antistreptolysin 0  titers of these sera had been determined  (9). 
In addition, antihyaluronidase levels of certain of these sera have been reported by Friou (10). 
Me.asurament of Inhibition  of  Desoxyribonudease.--(a)  Viscosimetric re.st.--With  minor 
modifications, the viscosimetric test is the same as that used in the measurement of the inhibi- 
tion of pancreatic desoxyribonudease by rabbit antisera (3). A  stock substrate solution was 
prepared  containing 0.1  per cent sodium desoxyribonucleate and 0.005  M MgSO4  in 0.025 
veronal buffer, pH 7.5. The enzyme and serum dilutions were prepared in neopeptone dialysate 
broth to insure stability. Although dilute solutions of the enzyme are unstable in buffer or 
gelatin, neopeptone broth solutions with enzyme concentrations as low as 0.02/~g./ml.  show 
no loss of activity during incubation. Equal volumes of the appropriate enzyme and serum 
dilution were mixed, incubated at 37* for 30 minutes, and 0.5 ml. of the mixture was added 
to 4.5 ml. of the substrate solution in an Ostwald viscosimeter for measurement of residual 
enzyme  activity. 
(b) Alcohol Precipitation Test.--The viscosimetric method is  a  relatively precise  method 
for the measurement of  desoxyribonuclease activity, but it has the disadvantage of being 
laborious and time-consuming. It is not adaptable to the titration of the antidesoxyribonudease 
activity of a  large number of sera such as those obtained by serial bleedings from patients 
with streptococcal infections. The following method, analogous in some respects to the mucin- 
clot prevention test for the measurement of  anti-hyaluronidase (11), was devised for this 
purpose.  The test is dependent upon  the fact that unchanged sodium  desoxyribonudeate 
when precipitated by alcohol forms a floating fibrous mass, and that after action of the enzyme 
only a  light flocculent precipitate is formed. 
Serial twofold dilutions of the sera, beginning at 1:10, were  prepared  in broth, and 0.25 
ml. of the dilutions was mixed in pyrex test tubes (10 X  100 ram.) with 0.25 ml. of a solution 
of streptococcal nuclease containing 0.2/~g./ml. After 30 minutes' incubation at  37"C., 0.5 
ml. of the substrate solution, prepared as above, was added to each tube and incubation con- 
tinued for 30 minutes. One ml. of ethyl alcohol was added to each tube at the end of the second 
incubation period and the tubes were examined for the presence of floating fibrous precipitate. 
The end point was defined as the highest serum dilution which prevented enzymatic degrada- 
tion of the substrate so that a  definite fibrious precipitate was formed upon the addition of 
alcohol. The final enzyme concentration in the reaction mixture (0.05/~g./ml.) is the equivalent 
of 5 units of enzyme in the viscosimetric system and is approximately four times the amount 
required to cause degradation of the desoxyribonucleate to a  point where no fibrous alcohol 
precipitate is formed under the conditions of the test. 
As in the case of other similar titrations dependent upon a  twofold serial dilution system, 
the titers are reproducible within one tube. Consequently, in attempting to determine whether 
a rise in antibody has occurred, a fourfold shift in titer is considered a significant change. 
Interfering Action of Serum Nuclease.--Since mammalian sera contain measurable amounts 
of desoxyribonudease, it was necessary to take this fact into consideration in devising pro- 
cedures in which serum was employed for its inhibitory action on streptococcal desoxyribo- 
nuclease. In the case of rabbit sera, which contain somewhat more of the enzyme than human 
sera, the action of the serum enzyme was detectable in the viscosimetrie test at serum con- 
1Sera and cultures on these patients were collected during a  cooperative project with the 
United States Naval Medical Research Unit No. 4. See reference 9. 546  INHIBITION OP  STREPTOCOCCAL DESOXYRIBONUCLEASE 
centrations employed in the inhibition test. Heating of the diluted serum at 65  ° C. for 30 
minutes destroys the enzyme without measurable effect on the antibody, and consequently 
this procedure was employed in all instances where dilutions of the serum of less than 1:80 
were involved. The concentration of nuclease in human serum is too low in the vast majority 
of cases to be a factor at the dilution employed  in this study. 
EXPERIMENTAL 
Inhibition  of Streptococcal Desoxyribonuclease by Rabbit Antisera.bln  com- 
parison with certain of the sera obtained from patients following streptococcal 
infections,  the sere from rabbits  injected with the purified enzyme did not 
possess high  inhibitory activity..However, tests  on sera of the  two rabbits 
giving the best response showed that by the viscosimetric test 1.0 cc. of serum 
was capable of almost complete inhibition of 5 units of enzyme and better than 
95 per cent inhibition of 50 units of enzyme. By the alcohol precipitation tech- 
nique an end point was obtained in both cases at a  serum  dilution of 1:640. 
There is no real discrepancy between the results obtained  by the two tech- 
niques, since they measure inhibition somewhat differently. By the viscosime- 
tric technique it is feasible only to measure rather high  degrees of inhibition, 
while by the alcohol precipitation technique a relatively small inhibitory effect 
would be reflected by a  preservation of part of the substrate in a  form that 
would give a fibrous precipitate. 
The specificity of rabbit antibody is of some interest. Desoxyribonuclease 
from beef pancreas,  which,  in so far as  has been determined, is an enzyme 
analogous  to  the  streptococcal  enzyme  in  its  action  on  desoxyribonudeic 
acid and in the optimal environmental conditions required, is entirely unaf- 
fected by  the  presence of rabbit  antiserum  against  streptococcal nuclease. 
Similarly,  antibody prepared in  the  same  manner using pancreatic  desoxy- 
ribonudease as  antigen  has  no  inhibitory action on  streptococcal nudease. 
These relationships are illustrated in part in Fig.  1. It will be observed that 
the  activity of approximately 1.5  units  of streptococcal desoxyribonudease 
is almost completely inhibited by homologous antiserum in a final dilution of 
1:25,  while the same  serum is without effect on a  similar concentration of 
pancreatic  desoxyribonuclease. Repeated  tests  using  varying concentrations 
of enzyme and serum in an attempt to increase the sensitivity of the measure- 
ments failed to reveal even a  slight degree of cross-reactivity; i.e., in no case 
did the effect of beterologous antiserum vary significantly from the effect of 
normal serum. 
These results have some theoretical interest since they indicate that in this 
case  the  configuration of  the  enzyme proteins which  determines enzymatic 
specificity is distinct from the  configuration conferring antigenic specificity. 
The action of the two enzymes appears to be identical, but this identity in 
enzyme action is not reflected by cross-reactivity in the  serological studies. 
The same phenomenon has been observed with more favorable material by ~c~.YN ~rccAxzY  547 
Krebs and  Najjar  (12).  These workers used crystalline preparations of d- 
glyceraldelyde-3 phosphate dehydrogenase from rabbit muscle and from yeast, 
and thus they were dealing with highly purified enzymes. In addition, the 
relative simplicity of the substrate and the enzyme reaction rendered it more 
certain that the enzyme action was identical in both cases.  They were able 
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Fro. 1. Effect of rabbit antiserum to streptococcal  desoxyrlbonucleas¢  on the activity of 
streptococcal and pancreatic desoxyribonucleases. 
to show that rabbit antiserum against yeast enzyme caused a marked degree of 
inhibition of the homologous enzyme but did not affect the activity of the 
rabbit muscle enzyme. 
The specificity of rabbit antibody against streptococcal desoxyribonuclease 
has been further demonstrated with respect to its action on other extracellular 
products of hemolytic streptococci. For example, the activity of streptokinase 
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Inhibilion  by Human 3era.--In approaching  the question of whether the 
human subject produces  antibody to streptococcal  desoxyribonudease follow- 
ing streptococcal  infections,  initial studies were made employing  the viscosi- 
metric test. It was found that although a high degree of variability existed in 
the apparent antibody response of various individuals following scarlet fever, 
the development of antibody  against this enzyme was pronounced in some cases. 
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Fxo. 2. Effect of human serum (obtained from patient 4 weeks after onset of scarlet fever) on 
streptococcal  desoxyribonudease.  Constant  enzyme  concentration  tested  against  varying 
dilutions of serum. 
An example of one of the latter cases is illustrated in Fig. 2. Serum obtained 
from this patient at the onset of scarlet fever was totally devoid of the capacity 
to inhibit the enzyme,  and subsequent bleedings  taken at weekly intervals 
showed a progressive increase in this property. The serum used in the experi- 
ment illustrated in Fig. 2 was obtained 4 weeks after onset of the infection and 
represents  the peak of antibody response. The inhibitory effect of the serum is 
further emphasized by the fact that a relatively high concentration of enzyme MACLYN McCARTY  549 
for the viscosimetric test---i.e., 0.25  ~g./ml. or 30 units--was employed. Fig. 
2 shows that even at a  final serum dilution of 1:20,000,  the serum causes a 
highly significant inhibition of the enzyme (90 per cent) and that with increasing 
concentration of serum up to  1:2000  complete inhibition  (99.6  per ce~t)  is 
approached. 
The specificity of human antibody to  streptococcal desoxyribonuclease is 
comparable to  that  of the rabbit  antisera.  Sera with high concentration of 
antibody, such as the one illustrated in Fig. 2, have no inhibitory action on 
pancreatic  desoxyribonudease or  on  a  sample  of  crude  desoxyribonuclease 
prepared from Pneumococcus (Type IIR). 
The frequency with which patients respond by formation of antibody to 
desoxyribonuclease and the relative magnitudes of the responses were deter- 
mined by applying the alcohol precipitation test to  the sera of 90 patients 
from an epidemic of scarlet fever at the Great Lakes Naval Training Center. 
The antibody response of these same patients to streptokinase and streptolysin 
O had previously  been determined, making possible a comparison of the antides- 
oxyribonudease data with those of two more commonly studied streptococcal 
antibodies (9). 
The results of the antinuclease determination show certain interesting dif- 
ferences from those obtained in the case of the other antibodies. 
1. The percentage of patients showing a significant response to desoxyribonu- 
dease (38 per cent) was definitely lower than in the case of streptokinase (61 
per cent) and streptolysin O  (70 per cent). Thirty-four of the 90 patients (33 
per cent) did not have measurable amounts of antibody to desoxyribonuclease 
by this relatively sensitive test at any time during the period in which sera were 
obtained. It would appear, therefore, that human beings respond by antibody 
formation to this extracellular antigen less frequently than to certain others, 
despite  the  fact  that  desoxyribonuclease  production  is  a  rather  constant 
property  of  hemolytic  streptococci.  Strains  isolated  from  patients  in  this 
epidemic were among those tested for production of the enzyme in vitro, and 
all these elaborated the enzyme in an amount comparable to that of the various 
stock laboratory strains. 
2. The values obtained for antidesoxyribonuclease titers are scattered over a 
wider range than in the case of the other two antibodies. Fifty-three of the 90 
patients had no demonstrable antinuclease at the time of onset of the scarlet 
fever and while many of these patients showed no subsequent rise others had 
increases in antibody up to as high as a serum dilution of 1 : 10,240. In the study 
of the antistreptokinase and antistreptolysin O  titers it was shown that the 
mean titers of those patients who developed rheumatic fever subsequent  to 
scarlet  fever were  significantly higher  than  those of  the  patients  with un- 
complicated  scarlet  fever.  The  spread  of  the  antidesoxyribonuclease titers 
renders a  comparable use of mean titers valueless in this small series of cases, 550  IB~I~ITION O~ STREPTocOCCAL DESOXYRIBONUCLEASE 
and it can only be said that analysis of the data suggests that a  comparable 
relationship holds in this case; i.e.,  that the rheumatic subjects on the average 
have a greater antibody response to desoxyribonuclease. 
3. The large number of patients showing no demonstrable antinuclease at 
the time of onset of scarlet fever is at variance with the fact that  the great 
majority of the patients had appreciable antistreptokinase and antistreptolysin 
TABLE I 
Ant~ecozyrlbonuclease  Titer$  of  Twenty-Three  Patient¢  with  Scarlet  Fe~er Followed by 
Rkeumat~  Fever 
CaN  No. 
0 
13  0 
16  320 
23  0 
30  10 
51  80 
52  0 
65  0 
88  10 
92  20 
120  0 
234  160 
247  80 
251  0 
61  20 
42  0 
45  0 
181  40 
175  40 
164  0 
173  0 
217  0 
337  40 
44  0 
Antidesoxyribonuclease  tlter 
Time  after onset of scarlet fever, ~Js. 
1  2  3  4-6 
40  1280 
0 
I0,  240 
0 
10 
80 
20 
40 
80 
40 
80 
320 
160 
10,240 
1280 
10,240 
640 
0 
20 
80 
320 
0 
80 
20 
640 
160 
160 
10,240 
5120 
0 
0 
80 
40 
0 
640 
0 
320 
0 
0 
0 
80 
20 
0 
640 
0 
40 
0 
O titers at this time, presumably as the result of previous experience with the 
hemolytic streptococcus. An explanation which suggests itself for this finding 
is  that  antidesoxyribonudease may be less stable  and  thus  disappear  more 
rapidly from the body than  the other two antibodies. However, no support 
for this explanation could be obtained from antibody studies in a few instances 
in which sera were available for many months following the scarlet fever. The 
rate of decrease of antidesoxyribonuclease titer in these cases was comparable 
to that of antistreptokinase. 
Certain of the facts summarized above are iUustrated in Table I, in which ~CL~  ~TY  551 
the  titers  of  antidesoxyribonuclease  (as  reciprocals  of  the  serum  dilution) 
are given for one group of the 90 patients. This group (designated group V in 
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Fro.  3. Comparison of antidesoxyribonuclease  response with antistreptokinase and  anti- 
streptolysin 0 titers in four patients following  scarlet fever. ASK-~- antistreptokinase, AS0: 
antistreptolysin 0, and ADN~  antidesoxyribonuclease. 
reference 9)  represents  those  patients  who  developed rheumatic fever as  s 
sequela of the scarlet fever. The case numbers are given so that direct compari- 
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Observations  previously made concerning the suppressive effect of penicillin 
therapy on antibody response  to extracellular  antigens of the streptococcus 
are confirmed by the antidesoxyribonuclease data. In a group of 17 patients who 
received "successful" penicillin therapy as indicated by the prompt and per- 
manent disappearance  of hemlytic streptococci  from the nasopharynx, none 
had significant rises in antistreptokinase and there were no rises as great as 
fourfold in the antistreptolysin O titer. Similarly only one of the 17 patients 
showed a significant rise in antidesoxyribonuclease  titer. 
Independent Variation of A ntibody Response to Different A ntigens.--Inspection 
of the antibody data from the 90 scarlet fever patients indicates that practically 
all possible combinations  of antibody response to the three extracellular  anti- 
gens occurred. This fact is illustrated by the results in four of these cases which 
are charted in Fig. 3. It will be noted that in case 55 excellent responses oc- 
curred to streptokinase and desoxyribonuclease, while there was no significant 
increase in antistreptolysin O. In case 217  there was no response to nuclease 
but a  good response  to the other two antigens, and conversely  in case 304 
there was a  response  only to nuclease.  An example  of a  patient showing a 
significant response only to streptolysin O is provided by case 30. In so far as 
in dtro tests can be relied on, it has been shown in the case of at least two of 
these  antigens--streptokinase  and  desoxyribonucleasc  that  the  variations 
are  not  attributable  to  quantitative  differences  in  the  amount of antigen 
produced by the strains. No study was made of the relative in vitro production 
of streptolysin O. The most reasonable assumption is that the variations repre- 
sent individual differences in the ability of the host to respond by the formation 
of antibody to a  given  streptococcal  protein. From the theoretical point of 
view it is of interest that the quantitative differences in antibody response do 
not merely reflect a general characteristic of the host that applies to all antigens 
of the streptococcal  cell, but they are specifically determined also by the nature 
of the individual antigen. 
SUMMARY 
Rabbit antisera against partially purified  streptococcal  desoxyribonuclease 
inhibit the action of the enzyme on its substrate. The activity of pancreatic 
desoxyribonudease is not affected by these antisera. Similarly antibody against 
pancreatic nuclease does not inhibit the streptococcal  enzyme. 
Certain patients develop  inhibitory antibody to streptococcal  desoxyribo- 
nuclease  following  streptococcal  infections,  occasionally  in  very high titer, 
although the proportion of patients showing an antibody response appears to 
be lower than in the case of streptokinase and streptolysin O. 
The pattern of antibody response to desoxyribonuclease has been compared 
to that of streptokinase and streptolysin O in a group of ninety patients from 
an epidemic of scarlet fever. MACLY'N MCCARTY  553 
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